Understanding the Aftermath of Brexit: Implications for the Pharmaceutical Industry Chie Hoon Song Commentary 18 August 2016 Pages: 253 - 256
Considerations for Successful Risk-Minimisation Strategies in the EU Janine CollinsDafna Bonneh-Barkay Current Opinion 26 September 2016 Pages: 257 - 261
Strategies and Systems-Level Interventions to Combat or Prevent Drug Counterfeiting: A Systematic Review of Evidence Beyond Effectiveness Racha FadlallahFadi El-JardaliElie A. Akl Systematic Review Open access 19 August 2016 Pages: 263 - 276
Analysis of the Drugs Withdrawn from the US Market from 1976 to 2010 for Safety Reasons Pierre La RochelleJoel LexchinDavid Simonyan Original Research Article 12 September 2016 Pages: 277 - 289
Evaluation of Pharmacovigilance Practice in Pharmaceutical Companies in Nigeria Obiyo NwaiwuOlayemi OyeladeChinwe Eze Original Research Article 27 July 2016 Pages: 291 - 295